Adm Diagnostics, Inc.

Northbrook, IL · Medtech · Private

AI diagnostic tool using brain MRI imaging and biomarkers to identify Chronic Traumatic Encephalopathy (CTE) in living patients

Claim this profile

Follows are private to you and power your alerts

Updated · admdx.com

Sector
Medtech
Headquarters
Northbrook, IL
Latest Form D
$520K, Mar 2018
Total capital
$3.8M
Federal grants
$3.3M
4 awards · 2018–2023
Rank in peer group#28 of 53
Private capital raised
$520K
1 Form D · last Mar 2018
104 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
1 pending · first 2020
Rank in peer group#14 of 53

Capital timeline

201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.8M$225K$208K$2M$913K1st Form D$520K
201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.8M$225K$208K$2M$913K1st Form D$520K

Latest events

  • Federal grantHealth and Human S · Phase II · Multi-modal machine learning detection and tracking of traumatic brain injury neurodegeneration and its differentiation from Alzheimer's disease$913K
  • Federal grantHealth and Human S · Phase II · Multi-modal machine learning detection and tracking of traumatic brain injury neurodegeneration and its differentiation from Alzheimer's disease$2M
  • Federal grantHealth and Human S · Phase I · Multi-modal machine learning detection and tracking of traumatic brain injury neurodegeneration and its differentiation from Alzheimer's disease$208K
  • Federal grantHealth and Human S · Phase I · Alzheimer's Amyloid and Tau Pathology Staging and Clinical Impact Prediction Using Multi-Modal MRI Pattern Classification$225K
  • Private capital raisedForm D · SEC · 1st filing$520K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 53 peers

Line = median

Medtech · Software

  • Federal grantsBelow median
  • Granted patents#14 · top 26%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Dawn C. MatthewsResearcherExecutive Officer, DirectorLinked by 2 patents
  • Miles C. WernickDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .